A detailed history of Greenleaf Trust transactions in Pfizer Inc stock. As of the latest transaction made, Greenleaf Trust holds 255,682 shares of PFE stock, worth $7.08 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
255,682
Previous 266,290 3.98%
Holding current value
$7.08 Million
Previous $7.67 Million 7.45%
% of portfolio
0.07%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $274,641 - $315,375
-10,608 Reduced 3.98%
255,682 $7.1 Million
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $1.08 Million - $1.4 Million
-41,316 Reduced 13.43%
266,290 $7.67 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $422,978 - $494,419
-13,181 Reduced 4.11%
307,606 $10.2 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $56,491 - $65,359
1,564 Added 0.49%
320,787 $11.8 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $146,136 - $190,248
3,710 Added 1.18%
319,223 $13 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $630,550 - $823,113
15,103 Added 5.03%
315,513 $16.2 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $170,751 - $208,444
3,902 Added 1.32%
300,410 $13.1 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $1.38 Million - $1.64 Million
29,755 Added 11.15%
296,508 $15.5 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $90,996 - $112,756
1,989 Added 0.75%
266,753 $13.8 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $397,705 - $589,531
9,625 Added 3.77%
264,764 $15.6 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $698,296 - $897,022
-17,791 Reduced 6.52%
255,139 $11 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $611,224 - $692,414
17,021 Added 6.65%
272,930 $10.7 Million
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $53,818 - $60,696
-1,607 Reduced 0.62%
255,909 $9.27 Million
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $639,745 - $813,491
19,114 Added 8.02%
257,516 $9.48 Million
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $158,273 - $185,691
4,985 Added 2.14%
238,402 $8.75 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $393,367 - $477,212
13,060 Added 5.93%
233,417 $7.63 Million
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $368,905 - $527,085
-13,648 Reduced 5.83%
220,357 $7.19 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $86,118 - $97,733
-2,616 Reduced 1.11%
234,005 $9.17 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $530,919 - $688,446
-16,341 Reduced 6.46%
236,621 $8.5 Million
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $62,496 - $70,168
1,690 Added 0.67%
252,962 $11 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $344,212 - $378,174
-9,179 Reduced 3.52%
251,272 $10.7 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $366,811 - $418,205
9,535 Added 3.8%
260,451 $11.4 Million
Q3 2018

Oct 29, 2018

BUY
$34.47 - $41.81 $853,132 - $1.03 Million
24,750 Added 10.94%
250,916 $11.1 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $483,091 - $515,023
14,648 Added 6.93%
226,166 $8.21 Million
Q1 2018

Apr 30, 2018

BUY
$31.91 - $37.02 $85,774 - $99,509
2,688 Added 1.29%
211,518 $7.51 Million
Q4 2017

Feb 08, 2018

BUY
$33.26 - $35.29 $205,280 - $217,809
6,172 Added 3.05%
208,830 $7.56 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $6.28 Million - $6.92 Million
202,658
202,658 $7.24 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.